Clinical Trial Update: ExAblate Blood-Brain Barrier Opening for Treatment of Alzheimer's Disease [NA]

View source ↗

Summary

This clinical trial update summarizes a completed study evaluating ExAblate blood-brain barrier opening as a treatment approach for Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Exablate

Snippet

Sponsor: InSightec | Conditions: Alzheimer Disease | NA | Status: COMPLETED